2023 Pharma Outlook – trends shaping the year ahead

Professional services company PwC has released a new report, PwC’s Next In Pharma and Life Sciences 2023 Report. This highlights the outlook for the pharmaceutical and life sciences industry, and the biggest c-suite agenda topics that will shape 2023.

Amid high inflation, talent shortages, rising capital costs, blockbuster patent expiries and the impact of the IRA – 90% of executives are worried about the macroeconomic environment. But according to the report, companies can seize this moment to transform their business in bold new ways.

In 2023, companies will need to reimagine work, tech-enable their organizations, and advance their portfolios to achieve multiple objectives simultaneously.